(1->4)-beta-D-glucan multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP2 mRNA CTD PMID:36331819 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of IGFBP2 mRNA CTD PMID:23825647 1,2-dichloroethane increases expression ISO Igfbp2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of IGFBP2 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine increases expression ISO Igfbp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of IGFBP2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP2 mRNA CTD PMID:25380136 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IGFBP2 protein CTD PMID:15817916 17alpha-ethynylestradiol decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of IGFBP2 mRNA CTD PMID:29097150 17alpha-ethynylestradiol affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ethinyl Estradiol affects the expression of IGFBP2 mRNA CTD PMID:12655037 and PMID:16079270 17alpha-ethynylestradiol increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased secretion of IGFBP2 protein more ... CTD PMID:15809018 more ... 17beta-estradiol decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of IGFBP2 mRNA CTD PMID:32145629 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:25878060 17beta-estradiol increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:26945725 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IGFBP2 mRNA CTD PMID:19619570 and PMID:21185374 17beta-estradiol increases secretion EXP 6480464 Estradiol results in increased secretion of IGFBP2 protein CTD PMID:15809018 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] and Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of IGFBP2 mRNA CTD PMID:16368782 2,2',4,4',5,5'-hexachlorobiphenyl affects expression EXP 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:31923581 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:20056577 and PMID:21394737 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGFBP2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:26290441 and PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp2 (Mus musculus) 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA] CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Igfbp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:19619570 more ... 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of IGFBP2 mRNA CTD PMID:30851411 2-nitrotoluene increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2-nitrotoluene results in increased expression of IGFBP2 mRNA CTD PMID:16460773 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Igfbp2 (Mus musculus) 6480464 3 more ... CTD PMID:37080397 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Igfbp2 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Triiodothyronine results in increased expression of IGFBP2 mRNA CTD PMID:15953391 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of IGFBP2 mRNA CTD PMID:25380136 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP2 mRNA CTD PMID:22484513 and PMID:23052194 4-hydroxyphenyl retinamide increases expression ISO Igfbp2 (Mus musculus) 6480464 Fenretinide results in increased expression of IGFBP2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of IGFBP2 mRNA] CTD PMID:21095227 5-fluorouracil increases expression ISO Igfbp2 (Mus musculus) 6480464 Fluorouracil results in increased expression of IGFBP2 protein CTD PMID:21296659 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of IGFBP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of IGFBP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of IGFBP2 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Alitretinoin results in increased expression of IGFBP2 mRNA CTD PMID:16648578 acrylamide decreases expression ISO Igfbp2 (Mus musculus) 6480464 Acrylamide results in decreased expression of IGFBP2 mRNA CTD PMID:35032568 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of IGFBP2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of IGFBP2 protein CTD PMID:20106945 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of IGFBP2 intron CTD PMID:30157460 aflatoxin B1 increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of IGFBP2 mRNA CTD PMID:23052194 and PMID:25378103 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP2 mRNA CTD PMID:21632981 and PMID:21641981 aflatoxin B1 decreases expression ISO Igfbp2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of IGFBP2 mRNA CTD PMID:19770486 Aflatoxin B2 alpha increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of IGFBP2 intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP2 protein] CTD PMID:16055936 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of IGFBP2 mRNA CTD PMID:15498508 more ... amiodarone affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Amiodarone affects the expression of IGFBP2 mRNA CTD PMID:19483382 ammonium chloride affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of IGFBP2 mRNA CTD PMID:16483693 anthracen-2-amine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2-anthramine results in increased expression of IGFBP2 mRNA CTD PMID:23038007 antimycin A decreases expression EXP 6480464 Antimycin A results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of IGFBP2 promoter CTD PMID:23974009 arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein and Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGFBP2 protein] CTD PMID:26598702 and PMID:27430728 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of IGFBP2 mRNA CTD PMID:15070760 and PMID:15761015 atrazine increases expression EXP 6480464 Atrazine results in increased expression of IGFBP2 mRNA CTD PMID:22378314 azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 benzbromarone affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of IGFBP2 mRNA CTD PMID:19483382 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of IGFBP2 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA CTD PMID:35870112 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of IGFBP2 exon and Benzo(a)pyrene results in increased methylation of IGFBP2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Igfbp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO Igfbp2 (Mus musculus) 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression ISO Igfbp2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of IGFBP2 mRNA CTD PMID:20127859 more ... benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of IGFBP2 mRNA CTD PMID:21632981 and PMID:22316170 benzo[a]pyrene decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO Igfbp2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of IGFBP2 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of IGFBP2 intron CTD PMID:30157460 Benzo[k]fluoranthene affects expression ISO Igfbp2 (Mus musculus) 6480464 benzo(k)fluoranthene affects the expression of IGFBP2 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGFBP2 mRNA CTD PMID:18164116 bexarotene increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 bexarotene results in increased expression of IGFBP2 mRNA CTD PMID:16648578 and PMID:17630414 bexarotene multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of IGFBP2 mRNA CTD PMID:17630414 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP2 mRNA CTD PMID:16368782 bicalutamide increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 bicalutamide results in increased expression of IGFBP2 mRNA CTD PMID:10604720 bicalutamide multiple interactions EXP 6480464 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 bisphenol A affects expression ISO Igfbp2 (Mus musculus) 6480464 bisphenol A affects the expression of IGFBP2 mRNA CTD PMID:26746108 bisphenol A decreases expression ISO Igfbp2 (Mus musculus) 6480464 bisphenol A results in decreased expression of IGFBP2 mRNA CTD PMID:37105096 bisphenol A decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of IGFBP2 mRNA CTD PMID:30816183 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP2 mRNA CTD PMID:27685785 bisphenol A affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of IGFBP2 mRNA CTD PMID:25181051 and PMID:30903817 bisphenol F decreases expression ISO Igfbp2 (Mus musculus) 6480464 bisphenol F results in decreased expression of IGFBP2 mRNA CTD PMID:36706583 bromobenzene increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of IGFBP2 mRNA CTD PMID:32479839 bromochloroacetic acid increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 bromochloroacetic acid results in increased expression of IGFBP2 mRNA CTD PMID:16460773 bromochloroacetic acid increases expression ISO Igfbp2 (Mus musculus) 6480464 bromochloroacetic acid results in increased expression of IGFBP2 protein CTD PMID:21296659 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP2 mRNA CTD PMID:29741670 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP2 mRNA and Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] CTD PMID:26138014 and PMID:29741670 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of IGFBP2 protein CTD PMID:26138014 calcium atom affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Calcium affects the expression of IGFBP2 mRNA CTD PMID:15913539 calcium(0) affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Calcium affects the expression of IGFBP2 mRNA CTD PMID:15913539 carbon nanotube decreases expression ISO Igfbp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 carbonyl sulfide increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 carbonyl sulfide results in increased expression of IGFBP2 mRNA CTD PMID:19395590 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:31923581 chloropicrin decreases expression EXP 6480464 chloropicrin results in decreased expression of IGFBP2 mRNA CTD PMID:26352163 and PMID:28476498 ciprofibrate increases expression ISO Igfbp2 (Mus musculus) 6480464 ciprofibrate results in increased expression of IGFBP2 mRNA CTD PMID:12771043 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of IGFBP2 mRNA CTD PMID:27594783 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of IGFBP2 mRNA CTD PMID:27392435 clobetasol increases expression ISO Igfbp2 (Mus musculus) 6480464 Clobetasol results in increased expression of IGFBP2 mRNA CTD PMID:27462272 clofibrate affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Clofibrate affects the expression of IGFBP2 mRNA CTD PMID:19483382 cocaine decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Cocaine results in decreased expression of IGFBP2 mRNA CTD PMID:16076954 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO Igfbp2 (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of IGFBP2 mRNA CTD PMID:29279043 Cuprizon increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of IGFBP2 mRNA CTD PMID:26577399 and PMID:27523638 curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein CTD PMID:27430728 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of IGFBP2 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of IGFBP2 mRNA CTD PMID:23640034 deguelin decreases expression EXP 6480464 deguelin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of IGFBP2 mRNA CTD PMID:25047013 dexamethasone decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of IGFBP2 mRNA CTD PMID:19853640 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP2 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of IGFBP2 mRNA CTD PMID:15070760 and PMID:15761015 diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein and Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGFBP2 protein] CTD PMID:26598702 and PMID:27430728 dibenz[a,h]anthracene increases expression ISO Igfbp2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of IGFBP2 mRNA CTD PMID:21266533 diclofenac decreases expression ISO Igfbp2 (Mus musculus) 6480464 Diclofenac results in decreased expression of IGFBP2 mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO Igfbp2 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of IGFBP2 mRNA CTD PMID:15171707 diethylstilbestrol decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Diethylstilbestrol results in decreased expression of IGFBP2 mRNA CTD PMID:36653537 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP2 mRNA CTD PMID:15766595 dioxygen multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP2 protein] CTD PMID:16055936 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of IGFBP2 mRNA CTD PMID:24236059 diuron increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Diuron results in increased expression of IGFBP2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 doxorubicin increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of IGFBP2 protein CTD PMID:8792405 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of IGFBP2 mRNA CTD PMID:19244175 ellagic acid increases expression EXP 6480464 Ellagic Acid results in increased expression of IGFBP2 mRNA CTD PMID:12002526 endosulfan decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of IGFBP2 mRNA CTD PMID:29391264 Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA CTD PMID:19167446 erythromycin estolate increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Erythromycin Estolate results in increased expression of IGFBP2 mRNA CTD PMID:24412560 ethanol affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ethanol affects the expression of IGFBP2 mRNA CTD PMID:11772933 fenpyroximate decreases expression EXP 6480464 fenpyroximate results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 fentin chloride increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 triphenyltin chloride results in increased expression of IGFBP2 mRNA CTD PMID:37156404 fluoxetine decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Fluoxetine results in decreased expression of IGFBP2 mRNA CTD PMID:17033635 flutamide multiple interactions EXP 6480464 Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 flutamide decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of IGFBP2 mRNA CTD PMID:24136188 furan increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 furan results in increased expression of IGFBP2 mRNA CTD PMID:26194646 genistein increases expression ISO Igfbp2 (Mus musculus) 6480464 Genistein results in increased expression of IGFBP2 mRNA CTD PMID:32186404 gentamycin decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of IGFBP2 mRNA CTD PMID:33387578 glycidol increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 glycidol results in increased expression of IGFBP2 mRNA CTD PMID:24395379 griseofulvin affects expression ISO Igfbp2 (Mus musculus) 6480464 Griseofulvin affects the expression of IGFBP2 mRNA CTD PMID:12735108 hexachlorobenzene multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:31923581 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of IGFBP2 mRNA CTD PMID:32949572 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of IGFBP2 protein CTD PMID:32959892 L-ethionine affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ethionine affects the expression of IGFBP2 mRNA CTD PMID:19483382 leflunomide increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 leflunomide results in increased expression of IGFBP2 mRNA CTD PMID:24136188 lidocaine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Lidocaine results in increased expression of IGFBP2 mRNA CTD PMID:35283115 lipopolysaccharide decreases expression ISO Igfbp2 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of IGFBP2 mRNA CTD PMID:27339419 lycopene increases expression EXP 6480464 lycopene results in increased expression of IGFBP2 protein CTD PMID:17337101 menadione decreases expression ISO Igfbp2 (Mus musculus) 6480464 Vitamin K 3 results in decreased expression of IGFBP2 mRNA CTD PMID:25270620 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of IGFBP2 intron CTD PMID:30157460 N-(6-acetamidohexyl)acetamide decreases expression ISO Igfbp2 (Mus musculus) 6480464 hexamethylene bisacetamide results in decreased expression of IGFBP2 mRNA CTD PMID:26941288 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] CTD PMID:26138014 N-methyl-N-nitrosourea decreases expression ISO Igfbp2 (Mus musculus) 6480464 Methylnitrosourea results in decreased expression of IGFBP2 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGFBP2 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO Igfbp2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of IGFBP2 mRNA CTD PMID:12771043 N-nitrosodimethylamine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of IGFBP2 mRNA CTD PMID:25380136 N-nitrosodimethylamine decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of IGFBP2 mRNA CTD PMID:17072980 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of IGFBP2 mRNA CTD PMID:25583101 nicotine increases expression EXP 6480464 Nicotine results in increased expression of IGFBP2 mRNA CTD PMID:23825647 nitrofen increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 nitrofen results in increased expression of IGFBP2 mRNA CTD PMID:33484710 omeprazole affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of IGFBP2 mRNA CTD PMID:19483382 ozone decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Ozone results in decreased expression of IGFBP2 mRNA CTD PMID:16330353 ozone multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IGFBP2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IGFBP2 mRNA CTD PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of IGFBP2 mRNA CTD PMID:23033980 p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of IGFBP2 mRNA CTD PMID:26760959 paracetamol affects expression ISO Igfbp2 (Mus musculus) 6480464 Acetaminophen affects the expression of IGFBP2 mRNA CTD PMID:15606129 paracetamol decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of IGFBP2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO Igfbp2 (Mus musculus) 6480464 Acetaminophen results in decreased expression of IGFBP2 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO Igfbp2 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of IGFBP2 mRNA] CTD PMID:29246445 perfluorohexanesulfonic acid decreases expression ISO Igfbp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of IGFBP2 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:31923581 perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of IGFBP2 mRNA CTD PMID:19162173 and PMID:21318169 perfluorooctanoic acid multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:31923581 phenformin increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Phenformin results in increased expression of IGFBP2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO Igfbp2 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of IGFBP2 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO Igfbp2 (Mus musculus) 6480464 Phenobarbital affects the expression of IGFBP2 mRNA CTD PMID:23091169 phenobarbital increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of IGFBP2 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO Igfbp2 (Mus musculus) 6480464 Phenobarbital results in decreased expression of IGFBP2 mRNA CTD PMID:19482888 PhIP increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of IGFBP2 mRNA CTD PMID:15215175 PhIP decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of IGFBP2 mRNA CTD PMID:15215175 picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IGFBP2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Igfbp2 (Mus musculus) 6480464 pirinixic acid results in increased expression of IGFBP2 mRNA CTD PMID:18301758 more ... pirinixic acid affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of IGFBP2 mRNA CTD PMID:19483382 pregnenolone 16alpha-carbonitrile increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP2 mRNA CTD PMID:19162173 and PMID:21318169 pregnenolone 16alpha-carbonitrile increases expression ISO Igfbp2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP2 mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile decreases expression ISO Igfbp2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP2 mRNA CTD PMID:27413110 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased secretion of IGFBP2 protein CTD PMID:15809018 progesterone increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Progesterone results in increased expression of IGFBP2 mRNA CTD PMID:19853640 progesterone increases secretion EXP 6480464 Progesterone results in increased secretion of IGFBP2 protein CTD PMID:15809018 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of IGFBP2 mRNA CTD PMID:18070364 pyrimidifen decreases expression EXP 6480464 pyrimidifen results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 quercetin increases expression EXP 6480464 Quercetin results in increased expression of IGFBP2 mRNA CTD PMID:21632981 rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of IGFBP2 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of IGFBP2 mRNA CTD PMID:12002526 and PMID:12569576 resveratrol multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IGFBP2 mRNA CTD PMID:25905778 riddelliine increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 riddelliine results in increased expression of IGFBP2 mRNA CTD PMID:18047727 rotenone increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Rotenone results in increased expression of IGFBP2 mRNA CTD PMID:28374803 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 RU 58668 affects expression EXP 6480464 RU 58668 affects the expression of IGFBP2 protein CTD PMID:15868441 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 selenium atom increases expression EXP 6480464 Selenium results in increased expression of IGFBP2 mRNA CTD PMID:19244175 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of IGFBP2 mRNA CTD PMID:23806026 silver atom decreases expression ISO Igfbp2 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Igfbp2 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP2 mRNA CTD PMID:27131904 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of IGFBP2 mRNA CTD PMID:12727804 sodium arsenate increases expression ISO Igfbp2 (Mus musculus) 6480464 sodium arsenate results in increased expression of IGFBP2 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO Igfbp2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of IGFBP2 mRNA CTD PMID:17350061 and PMID:17451858 sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of IGFBP2 mRNA CTD PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of IGFBP2 mRNA CTD PMID:12727804 sodium tungstate affects expression EXP 6480464 sodium tungstate(VI) affects the expression of IGFBP2 mRNA CTD PMID:26164860 streptozocin multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IGFBP2 mRNA CTD PMID:25905778 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of IGFBP2 mRNA CTD PMID:31533062 tamibarotene affects expression EXP 6480464 tamibarotene affects the expression of IGFBP2 mRNA CTD PMID:15498508 tamoxifen increases expression ISO Igfbp2 (Mus musculus) 6480464 Tamoxifen results in increased expression of IGFBP2 mRNA CTD PMID:17555576 tamoxifen multiple interactions ISO Igfbp2 (Rattus norvegicus) 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of IGFBP2 mRNA CTD PMID:17630414 tamoxifen decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Tamoxifen results in decreased expression of IGFBP2 mRNA CTD PMID:17630414 tebufenpyrad decreases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of IGFBP2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA CTD PMID:15336504 testosterone increases expression EXP 6480464 Testosterone results in increased expression of IGFBP2 mRNA and Testosterone results in increased expression of IGFBP2 protein CTD PMID:15817916 and PMID:16368782 tetrachloromethane decreases expression ISO Igfbp2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of IGFBP2 mRNA CTD PMID:27339419 and PMID:31919559 tetracycline decreases expression ISO Igfbp2 (Mus musculus) 6480464 Tetracycline results in decreased expression of IGFBP2 mRNA CTD PMID:24489787 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of IGFBP2 mRNA CTD PMID:22378314 thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of IGFBP2 mRNA CTD PMID:27188386 thioacetamide affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of IGFBP2 mRNA CTD PMID:19483382 thioacetamide decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of IGFBP2 mRNA CTD PMID:34492290 thioacetamide increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of IGFBP2 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO Igfbp2 (Mus musculus) 6480464 titanium dioxide results in increased expression of IGFBP2 mRNA and titanium dioxide results in increased expression of IGFBP2 protein CTD PMID:23409001 and PMID:23565150 titanium dioxide multiple interactions ISO Igfbp2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP2 mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of IGFBP2 mRNA CTD PMID:30012374 triclosan increases expression EXP 6480464 Triclosan results in increased expression of IGFBP2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO Igfbp2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of IGFBP2 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of IGFBP2 mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of IGFBP2 mRNA CTD PMID:25572481 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of IGFBP2 mRNA CTD PMID:22378314 valproic acid affects expression ISO Igfbp2 (Mus musculus) 6480464 Valproic Acid affects the expression of IGFBP2 mRNA CTD PMID:17292431 and PMID:17963808 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGFBP2 mRNA CTD PMID:19101580 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of IGFBP2 mRNA CTD PMID:25979313 valproic acid increases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of IGFBP2 mRNA CTD PMID:21318169 vemurafenib multiple interactions EXP 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of IGFBP2 protein CTD PMID:27169980 vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of IGFBP2 mRNA CTD PMID:19244175 vorinostat increases expression ISO Igfbp2 (Mus musculus) 6480464 vorinostat results in increased expression of IGFBP2 mRNA CTD PMID:26941288 zinc atom decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of IGFBP2 mRNA CTD PMID:12672911 zinc oxide affects expression ISO Igfbp2 (Rattus norvegicus) 6480464 Zinc Oxide affects the expression of IGFBP2 protein CTD PMID:33205376 zinc(0) decreases expression ISO Igfbp2 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of IGFBP2 mRNA CTD PMID:12672911
